E. Dybkjær

1.1k total citations
42 papers, 845 citations indexed

About

E. Dybkjær is a scholar working on Hematology, Epidemiology and Management of Technology and Innovation. According to data from OpenAlex, E. Dybkjær has authored 42 papers receiving a total of 845 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Hematology, 11 papers in Epidemiology and 8 papers in Management of Technology and Innovation. Recurrent topics in E. Dybkjær's work include Blood groups and transfusion (10 papers), Blood transfusion and management (8 papers) and Hepatitis B Virus Studies (8 papers). E. Dybkjær is often cited by papers focused on Blood groups and transfusion (10 papers), Blood transfusion and management (8 papers) and Hepatitis B Virus Studies (8 papers). E. Dybkjær collaborates with scholars based in Denmark, Switzerland and Germany. E. Dybkjær's co-authors include Hans Jørgen Nielsen, Nils Brünner, L Edvardsen, V. Reinicke, Anders N. Pedersen, Ross W. Stephens, Maria J. A. G. Hamers, Gunilla Høyer‐Hansen, Keld Danø and Ebbe Rønne and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Clinical Chemistry.

In The Last Decade

E. Dybkjær

39 papers receiving 770 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Dybkjær Denmark 13 247 243 215 151 107 42 845
Jacob Nusbacher United States 22 483 2.0× 107 0.4× 148 0.7× 10 0.1× 159 1.5× 48 1.2k
Steven R. Sloan United States 19 468 1.9× 465 1.9× 144 0.7× 46 0.3× 183 1.7× 58 1.4k
Paola Manzini Italy 19 255 1.0× 69 0.3× 1.1k 5.2× 157 1.0× 296 2.8× 41 1.8k
Georges Andreu France 15 233 0.9× 349 1.4× 48 0.2× 21 0.1× 243 2.3× 22 914
Renée M. Y. Barge Netherlands 23 504 2.0× 92 0.4× 197 0.9× 35 0.2× 379 3.5× 44 1.5k
J Gmür Switzerland 20 1.3k 5.2× 264 1.1× 229 1.1× 39 0.3× 212 2.0× 51 1.7k
M. Wolf Australia 15 725 2.9× 238 1.0× 63 0.3× 30 0.2× 201 1.9× 32 1.3k
Dudley P. Jackson United States 14 614 2.5× 68 0.3× 42 0.2× 28 0.2× 82 0.8× 22 1.2k
Kaaron Benson United States 10 166 0.7× 171 0.7× 35 0.2× 31 0.2× 182 1.7× 24 640
Hector C. Ramos United States 11 238 1.0× 29 0.1× 162 0.8× 35 0.2× 86 0.8× 13 1.3k

Countries citing papers authored by E. Dybkjær

Since Specialization
Citations

This map shows the geographic impact of E. Dybkjær's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Dybkjær with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Dybkjær more than expected).

Fields of papers citing papers by E. Dybkjær

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Dybkjær. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Dybkjær. The network helps show where E. Dybkjær may publish in the future.

Co-authorship network of co-authors of E. Dybkjær

This figure shows the co-authorship network connecting the top 25 collaborators of E. Dybkjær. A scholar is included among the top collaborators of E. Dybkjær based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Dybkjær. E. Dybkjær is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dybkjær, E.. (2015). Enzyme Methods for the Demonstration of Incomplete Antibodies. Proceedings of the International Society of Blood Transfusion. 23. 1030–1035.
2.
Osther, Kurt, Knud Højgaard, & E. Dybkjær. (2009). DEMONSTRATION OF A COMPLEMENT INACTIVATOR ON CULTURED CELLS FROM HUMAN MALIGNANT BRAIN TUMOURS. Acta Neurologica Scandinavica. 50(6). 681–689. 1 indexed citations
3.
Mynster, Tommie, E. Dybkjær, Claus M. Reimert, et al.. (1999). Prestorage leukofiltration of whole blood and SAGM blood prevents extracellular bioactive substance accumulation. Inflammation Research. 48(7). 363–368. 6 indexed citations
4.
Nielsen, Hans Jørgen, et al.. (1999). Prestorage leukocyte filtration may reduce leukocyte-derived bioactive substance accumulation in patients operated for burn trauma. Burns. 25(2). 162–170. 20 indexed citations
5.
Nielsen, Hans Jørgen, et al.. (1997). Bioactive substance accumulation and septic complications in a burn trauma patient: effect of perioperative blood transfusion?. Burns. 23(1). 59–63. 10 indexed citations
6.
Nielsen, Hans Jørgen, Flemming Skov, E. Dybkjær, et al.. (1997). Leucocyte and platelet‐derived bioactive substances in stored blood: effect of prestorage leucocyte filtration. European Journal Of Haematology. 58(4). 273–278. 24 indexed citations
7.
Nielsen, Hans Jørgen, Claus M. Reimert, A. Pedersen, et al.. (1996). Time‐dependent, spontaneous release of white cell‐ and platelet‐derived bioactive substances from stored human blood. Transfusion. 36(11-12). 960–965. 132 indexed citations
8.
Hofmann, Bo, Pia Afzelius, Johan Iversen, et al.. (1996). Buspirone, a serotonin receptor agonist, increases CD4 T-cell counts and modulates the immune system in HIV-seropositive subjects. AIDS. 10(12). 1339–1347. 20 indexed citations
9.
Nielsen, Hans Jørgen, et al.. (1996). Time-dependent histamine release from stored human blood products.. PubMed. 83(2). 259–62. 44 indexed citations
10.
Heltberg, Ole, Peter Gerner‐Smidt, Hans Jørn Kolmos, et al.. (1993). Nosocomial epidemic of Serratia marcescens septicemia ascribed to contaminated blood transfusion bags. Transfusion. 33(3). 221–227. 51 indexed citations
11.
Dahr, W., V. Vengelen‐Tyler, E. Dybkjær, & Konrad Beyreuther. (1989). Structural Analysis of Glycophorin A from Miltenberger Class VIII Erythrocytes. Biological Chemistry Hoppe-Seyler. 370(2). 855–860. 11 indexed citations
12.
Wantzin, P., et al.. (1986). Cost‐effectiveness of introducing a third‐generation test for HBsAg in Danish blood donors. Liver International. 6(3). 173–177. 1 indexed citations
13.
Wantzin, P., et al.. (1985). Screening of Danish blood donors for hepatitis B surface antigen using a third generation technique.. BMJ. 291(6498). 780–782. 2 indexed citations
14.
Jans, H, et al.. (1982). Circulating Immune Complexes in Healthy Persons. Scandinavian Journal of Rheumatology. 11(4). 194–198. 9 indexed citations
15.
Wantzin, P., Jan Aldershvile, H Jans, E. Dybkjær, & Jens Nielsen. (1981). The Prognosis of the Healthy HBsAg Carrier State. Scandinavian Journal of Gastroenterology. 16(8). 1077–1081. 5 indexed citations
16.
Dybkjær, E., Joyce Poole, & Carolyn M. Giles. (1981). A New Miltenberger Class Detected by a Second Example of Anek Type Serum. Vox Sanguinis. 41(5-6). 302–305. 13 indexed citations
17.
Dybkjær, E., et al.. (1974). Weak Lu9 Antigen in One Lu:‐6 Member of a Family. Vox Sanguinis. 26(1). 94–96. 2 indexed citations
18.
Reinicke, V. & E. Dybkjær. (1971). LIVER DISEASE IN CARRIERS OF Au ANTIGEN. The Lancet. 298(7732). 1032–1032. 3 indexed citations
19.
Dybkjær, E. & F Kissmeyer-Nielsen. (1967). Enzyme reacting specific auto-antibodies in individuals showing no signs of auto-immune haemolytic anaemia. Veterinary Record. 80(18). 429–442. 2 indexed citations
20.
Dybkjær, E.. (1966). A New Technique for the Quantitation of Haemagglutination*. Vox Sanguinis. 11(1). 21–32. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026